<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0003674'>Oxidative stress</z:mp> increases delayed neuronal <z:hpo ids='HP_0011420'>death</z:hpo> in the brain following <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>As a consequence, many attempts to reduce the damage resulting from <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> under more highly oxidized conditions have focused on treatments aimed at maintaining the redox equilibrium of the local environment </plain></SENT>
<SENT sid="2" pm="."><plain>This study demonstrates the synergistic effects of combining treatments with <z:chebi fb="0" ids="30314">alpha-lipoic acid</z:chebi> (LA) and vitamin E (VE) as an efficient measure to reduce the damage caused by <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Two oral therapeutic protocols were examined: intensive treatment (100 mg/kg LA and 140 mg/kg VE for 7 days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>) and prophylactic treatment (20 mg/kg LA and 50 mg/kg VE from 30 days before infarction up to the day of sacrifice) </plain></SENT>
<SENT sid="4" pm="."><plain>The prophylactic treatment reduced serum <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation, and diminished brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volume by approximately 50% </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, prophylactically treated rats showed a reduction in post-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> neurological scores </plain></SENT>
<SENT sid="6" pm="."><plain>No significant differences were found in the intensively treated group </plain></SENT>
<SENT sid="7" pm="."><plain>Our data indicate that pre-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> administration of the LA-VE <z:chebi fb="11" ids="22586">antioxidant</z:chebi> mixture reduced the volume of brain damaged and the functional consequences of <z:e sem="disease" ids="C0264978" disease_type="Disease or Syndrome" abbrv="">embolic infarction</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>These findings suggest that prophylaxis with an LA-VE mixture may be valuable in reducing cerebral damage levels in patients with a high risk of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>